Lipella Pharmaceuticals,
PRISM MarketView,
Biotech,
Healthcare,
PRISM DigitalMedia,
Pharmaceutical,
PRISM MediaWire,
NASDAQ,
LIPO,
Public Health
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
-Lipella Granted Two Orphan Drug Designations by FDA-
Premier Press Release Services
Newswire Reimagined: Reach more investors, media and customers with precision targeting.